Grant: Discovery Grants Program - Individual
University of Waterloo
$27,000.00
Statistical and computational model for high dimensional data analysis
EF 2024-25
Résumé
My proposed research will be on methodological advancement in feature selection, classification, and predication, and their applications on drug discovery processes. A drug is often a small molecule that interacts with the binding sites of some target proteins involving in a given disease. The process is generally divided into three main stages: (i) lead molecule discovery; (ii) clinical trials; and (iii) regulatory approval and reimbursement. This is a time consuming and costly process. Computer-Aided Drug Design (CADD) is a specialized discipline that uses statistical models and computational algorithms to speed up and facilitate the discovery process.
The long-term objective of my NSERC DG research program is to develop effective and efficient statistical and computational methods for analyzing diverse types of high dimensional data. In the next 5 years, my short-term objectives are to make advances in two main themes: 1) computational drug discovery: from pharmacoinformatics to pharmacoeconomics; and 2) individual-level modeling of infectious diseases in large populations.
The proposed research provides new strategies for CADD and will have direct impact on the planning stage of the research and development of new drugs. New territory in the research area of CADD will be explored by using pharmacoeconomics related data to guide the drug discovery processes via multi-task statistical learning. The proposed methodological enhancement for individual-level and state space model in computational efficiency and predictability using approximate Bayesian computation method and statistical learning algorithms would enable the possibility of performing infectious disease modeling in large population. Beside, we also aim to develop a statistical framework to accurately estimate the population prevalence for various infectious diseases including the undiagnosed population using partially available observation data.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2023-03471
Name nom
Wong, William Wai Lun
Department département
School of Pharmacy
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
27000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1508
Committee name en
Mathematics and Statistics
Committee name fr
Mathématiques et statistique
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3004
Research subject group en
Statistics and probability
Research subject group fr
Statistique et probabilité
Research subject en
Applied statistics
Research subject fr
Statistique appliquée
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Statistical and computational model for high dimensional data analysis
Keywords
infectious disease modelling; computer-aided drug discovery; statistical learning; feature selection; kernel methods; pharmacoinformatics
Application summary
My proposed research will be on methodological advancement in feature selection, classification, and predication, and their applications on drug discovery processes. A drug is often a small molecule that interacts with the binding sites of some target proteins involving in a given disease. The process is generally divided into three main stages: (i) lead molecule discovery; (ii) clinical trials; and (iii) regulatory approval and reimbursement. This is a time consuming and costly process. Computer-Aided Drug Design (CADD) is a specialized discipline that uses statistical models and computational algorithms to speed up and facilitate the discovery process.
The long-term objective of my NSERC DG research program is to develop effective and efficient statistical and computational methods for analyzing diverse types of high dimensional data. In the next 5 years, my short-term objectives are to make advances in two main themes: 1) computational drug discovery: from pharmacoinformatics to pharmacoeconomics; and 2) individual-level modeling of infectious diseases in large populations.
The proposed research provides new strategies for CADD and will have direct impact on the planning stage of the research and development of new drugs. New territory in the research area of CADD will be explored by using pharmacoeconomics related data to guide the drug discovery processes via multi-task statistical learning. The proposed methodological enhancement for individual-level and state space model in computational efficiency and predictability using approximate Bayesian computation method and statistical learning algorithms would enable the possibility of performing infectious disease modeling in large population. Beside, we also aim to develop a statistical framework to accurately estimate the population prevalence for various infectious diseases including the undiagnosed population using partially available observation data.